Abstract
Classic Hodgkin’s lymphoma (cHL) most often involves lymph nodes, and gastric involvement is rare. Hodgkin’s and Reed-Sternberg (H-RS) cells in cHL are known to often lack expression of several B-lineage markers, such as CD20, CD79a, Oct-2, and Bob-1. We present an extremely rare case of mixed-cellularity cHL in the stomach in which expression of these B-cells was detected immunohistochemically. The patient was an 83-year-old Japanese woman who developed a sensation of abdominal fullness and appetite loss. Endoscopic and abdominal computed tomography examinations revealed a gastric ulcer lesion and swelling of para-aortic lymph nodes, respectively. A subtotal gastrectomy was performed, and the histopathologic diagnosis was established as a typical cHL compatible with stomach origin. The patient underwent postoperative chemotherapy of 3 cycles of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and has since been in complete remission. Immunohistochemically, the H-RS cells in the cHL were positive not only for CD30 but also for CD20, CD79a, Oct-2, and Bob-1, whereas they were negative for CD3, CD15, CD45, EMA, and ALK1. Our patient may have had an intermediate cHL disease overlapping that of non-Hodgkin’s peripheral B-cell lymphoma, possibly reflecting derivation from germinal-center B-cells.
Similar content being viewed by others
References
Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
Wood NL, Coltman CA. Localized primary extranodal Hodgkin’s disease. Ann Intern Med. 1973;78:113–118.
Devancy K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin disease [abstract]. American Society of Clinical Pathologists and College of American Pathologists Annual Meeting, New Orleans, Louisiana. 1990;93:449. Abstract 73.
Colucci G, Giotta F, Maiello E, Fucci L, Caruso ML. Primary Hodgkin’s disease of the stomach: a case report. Tumori. 1992;78:280–282.
Mori N, Yatabe Y, Narita M, et al. Primary gastric Hodgkin’s disease: morphologic, immunohistochemical, and immunogenetic analyses. Arch Pathol Lab Med. 1995;119:163–166.
Ogawa Y, Chung YS, Nakata B, et al. A case of primary Hodgkin’s disease of the stomach. J Gastroenterol. 1995;30:103–107.
Doweiko J, Dezube BJ, Pantanowitz L. Unusual sites of Hodgkin’s lymphoma, case 1: HIV-associated Hodgkin’s lymphoma of the stomach. J Clin Oncol. 2004;22:4227–4228.
Küppers R, Rajewsky K, Zhao M, et al. Hodgkin’s disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc NatlAcad Sci USA. 1994;91:10962–10966.
Tamaru J, Hummel M, Zemlin M, Kalvelage B, Stein H. Hodgkin’s disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood. 1994;84:708–715.
Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin’s disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med. 1995;333:901–906.
Re D, Thomas RK, Behringer K, Diehl V. From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood. 2005;105:4553–4560.
Küppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N EnglJ Med. 1999;341:1520–1529.
Korkolopoulou P, Cordell J, Jones M, et al. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin’s disease. Histopathology. 1994;24:511–515.
von Wasielewski R, Mengel M, Fischer R, et al. Classical Hodgkin’s disease: clinical impact of the immunophenotype. Am J Pathol. 1997;151:1123–1130.
Re D, Müdiger T, Marx A, Müschen M, Ahmadi T, et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res. 2001;61:2080–2084.
Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/ OBF.1 and Oct2 in classical Hodgkin’s disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496–501.
Loddenkemper C, Anagnostopoulos I, Hummel M, et al. Differential E? enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol. 2004;202:60–69.
Garcia-Cosio M, Santon A, Martin P, et al. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin’s lymphoma. Mod Pathol. 2004;17:1531–1538.
Orba Y, Tanaka S, Nishihara H, et al. Application of laser capture microdissection to cytologic specimens for the detection of immunoglobulin heavy chain gene rearrangement in patients with malignant lymphoma. Cancer. 2003;99:198–204.
Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin’s disease provides further evidence for its B-cell origin. Blood. 1999;94:3108–3113.
Stein H, Foss HD, Dürkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681–3695.
Lai R, Medeiros LJ, Dabbagh L, Formenti KS, Coupland RW. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma. Mod Pathol. 2000;13:223–228.
Haralambieva E, Pulford KA, Lamant L, et al. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas. Br J Haematol. 2000;109:584–591.
Garcia JF, Mollejo M, Fraga M, et al. Large B-cell lymphoma with Hodgkin’s features. Histopathology. 2005;47:101–110.
Brauninger A, Hansmann ML, Strickler JG, et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin’s disease and non-Hodgkin’s lymphoma. N Engl J Med. 1999;340:1239–1247.
Zettl A, Rüdiger T, Marx A, Müller-Hermelink HK, Ott G. Composite marginal zone B-cell lymphoma and classical Hodgkin’s lymphoma: a clinicopathological study of 12 cases. Histopathology. 2005;46:217–228.
Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol. 1999;12:200–217.
Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16–26.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Saito, M., Tanaka, S., Mori, A. et al. Primary Gastric Hodgkin’s Lymphoma Expressing a B-Cell Profile Including Oct-2 and Bob-1 Proteins. Int J Hematol 85, 421–425 (2007). https://doi.org/10.1532/IJH97.06094
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.06094